Skip to main content
. 2016 Jul 20;19(7):445–452. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2016.07.06

8.

注:本图得到版权所有者©2011-2016 Journal of Thoracic Disease复制许可。

诱导治疗后降期亚组5年生存率与直接手术组接近(93.8% vs 85.2%, P=0.438), 两组均优于诱导治疗后未降期亚组(P < 0.001)。

For locally advanced thymic malignancies, 5-year OS of downstage patients after induction therapy in IT group was similar to those in the DS group (93.8% vs 85.2%, P=0.438), both significantly greater than undownstage subgroup (P < 0.001).